🇺🇸 Intralipid 10% in United States

FDA authorised Intralipid 10% on 7 October 1975

Marketing authorisations

FDA — authorised 7 October 1975

  • Application: NDA017643
  • Marketing authorisation holder: FRESENIUS
  • Local brand name: INTRALIPID 10%
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

Intralipid 10% in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Intralipid 10% approved in United States?

Yes. FDA authorised it on 7 October 1975; FDA has authorised it.

Who is the marketing authorisation holder for Intralipid 10% in United States?

FRESENIUS holds the US marketing authorisation.